...
首页> 外文期刊>Journal of the American Chemical Society >Peptidomimetic Polyurethanes Inhibit Bacterial Biofilm Formation and Disrupt Surface Established Biofilms
【24h】

Peptidomimetic Polyurethanes Inhibit Bacterial Biofilm Formation and Disrupt Surface Established Biofilms

机译:肽模拟聚氨酯抑制细菌生物膜形成和破坏表面已建立生物膜

获取原文
获取原文并翻译 | 示例
           

摘要

Over 80% of all chronic bacterial infections in humans are associated with biofilms, which are surface-associated bacterial communities encased within a secreted exopolysaccharide matrix that can provide resistance to environmental and chemical insults. Biofilm formation triggers broad adaptive changes in the bacteria, allowing them to be almost 1000-fold more resistant to conventional antibiotic treatments and host immune responses. The failure of antibiotics to eliminate biofilms leads to persistent chronic infections and can promote the development of antibiotic-resistant strains. Therefore, there is an urgent need to develop agents that effectively prevent biofilm formation and eradicate established biofilms. Herein, we present water-soluble synthetic peptidomimetic polyurethanes that can disrupt surface established biofilms of Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli, all of which show tolerance to the conventional antibiotics polymyxin B and ciprofloxacin. Furthermore, while these polyurethanes show poor antimicrobial activity against planktonic bacteria, they prevent surface attachment and stimulate bacterial surface motility to inhibit biofilm formation of both Gram-positive and Gram-negative bacteria at subinhibitory concentrations, without being toxic to mammalian cells. Our results show that these polyurethanes show promise as a platform for the development of therapeutics that target biofilms and modulate surface interactions of bacteria for the treatment of chronic biofilm-associated infections and as antibiofilm agents.
机译:人类中慢性细菌感染的80%以上与生物膜有关,该生物膜是在分泌的外偶乙醛基质中包封的表面相关的细菌社区,可以提供对环境和化学损伤的抵抗力。生物膜形成触发细菌的广泛适应性变化,使它们耐受常规抗生素治疗和宿主免疫应答的抗性近1000倍。抗生素未能消除生物膜的失败导致持续的慢性感染,可以促进抗生素抗性菌株的发育。因此,迫切需要开发有效防止生物膜形成和根除已建立的生物膜的药剂。在此,我们存在水溶性合成肽模拟聚氨酯,其可以破坏表面已建立的铜绿假单胞菌,金黄色葡萄球菌和大肠杆菌的表面已建立的生物膜,所有这些都表现出对常规抗生素多粘蛋白B和环丙沙星的耐受性。此外,虽然这些聚氨酯对浮游细菌具有差的抗菌活性,但是防止表面附着并刺激细菌表面活力,以抑制子抑制浓度的革兰氏阳性和革兰氏阴性细菌的生物膜形成,而不会对哺乳动物细胞进行毒性。我们的研究结果表明,这些聚氨酯表明承诺作为靶向生物膜的治疗方法和调节细菌的表面相互作用,以治疗慢性生物膜相关感染和作为抗抗氧化铝剂的平台。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2021年第25期|9440-9449|共10页
  • 作者单位

    School of Polymer Science and Polymer Engineering The University of Akron Akron Ohio 44325 United States;

    School of Polymer Science and Polymer Engineering The University of Akron Akron Ohio 44325 United States;

    School of Polymer Science and Polymer Engineering The University of Akron Akron Ohio 44325 United States;

    Department of Biology The University of Akron Akron Ohio 44325 United States;

    School of Polymer Science and Polymer Engineering The University of Akron Akron Ohio 44325 United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号